Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Journal of Biopharmaceutical Statistics
|
September 22, 2007
Analysis of treatment effectiveness in longitudinal observational data
Douglas Faries, Haya Ascher-Svanum, Mark Belger
Schizophrenia Bulletin
|
May 2, 2007
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone
Mark Olfson, Steven C Marcus, Haya Ascher-Svanum
Cost Effectiveness and Resource Allocation : C/E
|
May 29, 2009
Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
Douglas E Faries, Allen W Nyhuis, Haya Ascher-Svanum
The American Journal of Managed Care
|
January 24, 2004
The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting
Haya Ascher-Svanum, John S Kennedy, David Lee, et al.
BMC Psychiatry
|
January 15, 2005
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
Haya Ascher-Svanum, Michael Stensland, Zhongyun Zhao, et al.
Annals of General Hospital Psychiatry
|
June 4, 2004
A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2010
Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study
Stephen Z Levine, Jonathan Rabinowitz, Michael Case, et al.
Administration and Policy in Mental Health
|
July 12, 2003
Clinical comparability of schizophrenia patients at two public mental health systems
Haya Ascher-Svanum, Baojin Zhu, Michael D Stensland, et al.
Journal of Clinical Psychopharmacology
|
September 17, 2008
The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials
Bruce J Kinon, Haya Ascher-Svanum, David H Adams, et al.
The Journal of Mental Health Policy and Economics
|
October 6, 2010
Costs associated with attempted suicide among individuals with bipolar disorder
Michael D Stensland, Baojin Zhu, Haya Ascher-Svanum, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Journal of Biopharmaceutical Statistics
|
September 22, 2007
Analysis of treatment effectiveness in longitudinal observational data
Douglas Faries, Haya Ascher-Svanum, Mark Belger
Schizophrenia Bulletin
|
May 2, 2007
Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone
Mark Olfson, Steven C Marcus, Haya Ascher-Svanum
Cost Effectiveness and Resource Allocation : C/E
|
May 29, 2009
Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
Douglas E Faries, Allen W Nyhuis, Haya Ascher-Svanum
The American Journal of Managed Care
|
January 24, 2004
The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting
Haya Ascher-Svanum, John S Kennedy, David Lee, et al.
BMC Psychiatry
|
January 15, 2005
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
Haya Ascher-Svanum, Michael Stensland, Zhongyun Zhao, et al.
Annals of General Hospital Psychiatry
|
June 4, 2004
A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2010
Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study
Stephen Z Levine, Jonathan Rabinowitz, Michael Case, et al.
Administration and Policy in Mental Health
|
July 12, 2003
Clinical comparability of schizophrenia patients at two public mental health systems
Haya Ascher-Svanum, Baojin Zhu, Michael D Stensland, et al.
Journal of Clinical Psychopharmacology
|
September 17, 2008
The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials
Bruce J Kinon, Haya Ascher-Svanum, David H Adams, et al.
The Journal of Mental Health Policy and Economics
|
October 6, 2010
Costs associated with attempted suicide among individuals with bipolar disorder
Michael D Stensland, Baojin Zhu, Haya Ascher-Svanum, et al.
Page
of 11